Dunnigan familial partial lipodystrophy information
Medical condition
Familial Partial Lipodystrophy, Dunnigan Type
Autosomal dominant is the manner of inheritance of this condition
Dunnigan-type familial partial lipodystrophy, also known as FPLD Type II and abbreviated as (FPLD2), is a rare monogenic form of insulin resistance characterized by loss of subcutaneous fat from the extremities, trunk, and gluteal region. FPLD recapitulates the main metabolic attributes of the insulin resistance syndrome, including central obesity, hyperinsulinemia, glucose intolerance and diabetes[1] usually type 2,[2] dyslipidemia, hypertension,[1] and early endpoints of atherosclerosis.[2] It can also result in hepatic steatosis.[3] FPLD results from mutations in LMNA gene, which is the gene that encodes nuclear lamins A and C.[1] The condition is named after Scottish doctor Matthew Dunnigan, who pioneered early study into the disorder. [4]
^ abcHegele, RA (December 2000). "Familial partial lipodystrophy: A monogenic form of the insulin resistance syndrome". Molecular Genetics and Metabolism. 71 (4): 539–44. doi:10.1006/mgme.2000.3092. PMID 11136544.
^ abHegele, RA (September 2000). "Insulin resistance in human partial lipodystrophy". Current Atherosclerosis Reports. 2 (5): 397–404. doi:10.1007/s11883-000-0078-0. PMID 11122771. S2CID 38167209.
^Ludtke, A; Genschel, J; Brabant, G; Bauditz, J; et al. (October 2005). "Hepatic steatosis in Dunnigan-type familial partial lipodystrophy". The American Journal of Gastroenterology. 100 (10): 2218–24. doi:10.1111/j.1572-0241.2005.00234.x. PMID 16181372. S2CID 23356132.
^Köbberling, J; Dunnigan, M (1986). "Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state". Journal of Medical Genetics. 23 (2): 120–127. doi:10.1136/jmg.23.2.120. PMC 1049565. PMID 3712389.
and 8 Related for: Dunnigan familial partial lipodystrophy information
Dunnigan-type familialpartiallipodystrophy, also known as FPLD Type II and abbreviated as (FPLD2), is a rare monogenic form of insulin resistance characterized...
Familialpartiallipodystrophy, also known as Köbberling–Dunnigan syndrome, is a rare genetic metabolic condition characterized by the loss of subcutaneous...
Berardinelli-Seip congenital lipodystrophy, Dunniganfamilialpartiallipodystrophy) and acquired (e.g., HIV-related lipodystrophy in people treated with highly...
2013). "Increased skeletal muscle volume in women with familialpartiallipodystrophy, Dunnigan variety". The Journal of Clinical Endocrinology and Metabolism...
2013). "Increased skeletal muscle volume in women with familialpartiallipodystrophy, Dunnigan variety". The Journal of Clinical Endocrinology and Metabolism...
"Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familialpartiallipodystrophy". Human Molecular Genetics. 9 (1): 109–112. doi:10.1093/hmg/9...